stroke
ATTENTION: VIOXX CLIENTS
In Canada the National Vioxx Class Action is proceeding after the dismissal of the final appeals by Merck. Mr. Justice Cullity has set directions for the next steps which include the opportunity for people to opt before June 30,2010. We will be advising each of our clients on this issue. If you are not yet represented for a Vioxx claim and believe your claim to be one of serious injury contact our firm to ensure that your rights are protected.
DECISION 2010: Canadian Vioxx Claims
The anti-inflammatory drug Vioxx was recalled over five years ago September 30, 2004 after evidence came out that it causes stroke and heart attacks. Since then the Miskin firm has represented individual Vioxx users hurt by that drug who are making claims. In the USA a settlement is still being implemented for over two years and Merck recently paid the final installment of settlement money as US claims are processed. Meanwhile Merck still fights a class action lawsuit in Canadian courts and has not yet paid any claims. In 2010 the fight to get Canadians compensation has finally moved to the next stage with certification finalized and finally directions for the class action coming through the Ontario Court. Vioxx claimants now have a decision to make.
Miskin Law proceeding across Canada with Yaz/Yasmin claims
The Bayer birth control pills Yaz or Yasmin can cause dehydration which causes an increase in the
potassium levels (hyperkalemia) and a decrease in the sodium levels (hyponatremia) in the body.
As potassium acts as a key control in cardiac rhythm, this imbalance can cause hyperkalemia
arrhythmias, which, in turn can cause blood clots and thrombotic events such as stroke or deep
vein thrombosis, pulmonary embolism, or heart attack. Dehydration is also a risk factor for
kidney stones and gallbladder disease. While other birth control pills can also cause thrombotic events, the cause of those effects are from the estrogen side of the equation. The thrombotic effects of Yaz and Yasmin are from the progesterin side. While it has long been accepted that high estrogen levels can cause these
adverse events, Yaz/Yasmin/Ocella have been marketed as having low estrogen levels, thereby
having a lower risk for thrombotic events. There have been several studies that have
called this into question.
The Miskin Law firm is making claims related to these drugs and class action court actions have been started in Ontario and Saskatchewan. The class action proceedings stop individual law suits from proceeding for now. We represent people to get them compensation both individually and through the class action process. Contact us if you believe you have been harmed by Yaz or Yasmin.
Asbestos Lawyer Canada | Ontario Personal Injury Lawyer | Ontario Real Estate Lawyer
Recent Comments